Free Access
Med Sci (Paris)
Volume 37, Novembre 2021
Les Cahiers de Myologie
Page(s) 32 - 35
Section Prise en charge
Published online 08 December 2021
  1. Ashizawa T, Gagnon C, Groh WJ, et al. Consensus-based care recommendations for adults with myotonic dystrophy type 1. Neurol Clin Pract 2018 ; 8 : 507–520. [CrossRef] [PubMed] [Google Scholar]
  2. Gutiérrez Gutiérrez G, Díaz-Manera J, Almendrote M, et al. Clinical guide for the diagnosis and follow-up of myotonic dystrophy type 1, MD1 or Steinert’s disease. Med Clin (Barc) 2019; 153 : 82.e1-17. [CrossRef] [Google Scholar]
  3. Pagola-Lorz I, Vicente E, Ibáñez B, et al. Epidemiological study and genetic characterization of inherited muscle diseases in a northern Spanish region. Orphanet J Rare Dis 2019 ; 14 : 276. [CrossRef] [PubMed] [Google Scholar]
  4. López de Munain A, Blanco A, Emparanza JI, et al. Prevalence of myotonic dystrophy in Guipúzcoa (Basque country, Spain). Neurology 1993 ; 43 : 1573–1576. [CrossRef] [PubMed] [Google Scholar]
  5. AFM. Enquête auprès de personnes atteintes de la dystrophie myotonique de Steinert. AFM-Téléthon, Myobase, 2011. [Google Scholar]
  6. Howe SJ, Marigold foundation, The Christopher project reference group. The Christopher Project. Report to the myotonic dystrophy community. Myotonic 2019. [Google Scholar]
  7. Merlevede K, Vermander D, Theys P, et al. Cardiac involvement and CTG expansion in myotonic dystrophy. J Neurol 2002 ; 249 : 693–698. [CrossRef] [PubMed] [Google Scholar]
  8. Groh WJ, Groh MR, Saha C, et al. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med 2008 ; 358 : 2688–2697. [CrossRef] [PubMed] [Google Scholar]
  9. de Die-Smulders CE, Höweler CJ, Thijs C, et al. Age and causes of death in adult-onset myotonic dystrophy. Brain 1998 ; 121 : 1557–1563. [CrossRef] [PubMed] [Google Scholar]
  10. Mathieu J, Allard P, Potvin L, et al. A 10-year study of mortality in a cohort of patients with myotonic dystrophy. Neurology 1999 ; 52 : 1658–1662. [CrossRef] [PubMed] [Google Scholar]
  11. Monteiro R, Bento J, Gonçalves MR, et al. Genetics correlates with lung function and nocturnal ventilation in myotonic dystrophy. Sleep Breath 2013 ; 17 : 1087–1092. [CrossRef] [PubMed] [Google Scholar]
  12. Boussaïd G, Wahbi K, Laforet P, et al. Genotype and other determinants of respiratory function in myotonic dystrophy type 1. Neuromuscul Disord 2018 ; 28 : 222–228. [CrossRef] [PubMed] [Google Scholar]
  13. Dogan C, De Antonio M, Hamroun D, et al. Gender as a modifying factor influencing myotonic dystrophy type 1 phenotype severity and mortality: a nationwide multiple databases cross-sectional observational study. PLoS One 2016 ; 11 : e0148264. [Google Scholar]
  14. Seijger CGW, Drost G, Posma JM, et al. Overweight is an independent risk factor for reduced lung volumes in myotonic dystrophy type 1. PLoS One 2016 ; 11 : e0152344. [Google Scholar]
  15. Groh WJ, Groh MR, Shen C, et al. Survival and CTG repeat expansion in adults with myotonic dystrophy type 1. Muscle Nerve 2011 ; 43 : 648–651. [CrossRef] [PubMed] [Google Scholar]
  16. Donzé C, Delattre S, Viet G, et al. Neuromuscular disease: health care accessibility in the Nord-Pas-de-Calais region. Rev Neurol (Paris) 1999 ; 155 : 1063–1070. [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.